GE HealthCare Technologies (GEHC) is back in focus after third quarter 2026 earnings beat expectations, full year guidance moved higher, and management paired the update with the planned SOFIE Biosciences acquisition.
GE HealthCare Technologies has enjoyed a strong near term rebound, with a 17.13% 1 month share price return and 12.57% 3 month share price return, yet the share price is still down 7.55% year to date while the 1 year total shareholder return is 2.37%. This suggests recent momentum has picked up after a softer stretch earlier in 2026 as investors reassess growth prospects and risk around the latest earnings beat, product launches and clinical collaborations.
Scan how GE HealthCare Technologies stacks up against other hospital equipment and diagnostics players by checking a curated set of 34 healthcare AI stocks that are also riding fresh product and clinical momentum.
For GE HealthCare Technologies, the rebound now looks tightly linked to earnings, guidance and SOFIE rather than a rising sector tide. The next step is to ask what the current price implies about that story.
Most Popular Narrative: 11.8% Undervalued
On the latest numbers, GE HealthCare Technologies closed at $76.57 while the most followed narrative pegs fair value at $86.80. The gap between price and story is meaningful enough that the assumptions behind it matter.
The current narrative that GE HealthCare Technologies is undervalued implies that the share price does not fully reflect the record backlog, the contribution from higher margin Advanced Imaging Solutions and Pharmaceutical Diagnostics, and the expected multiyear contribution from Flyrcado and other new products.
See why 78 investors see GE HealthCare Technologies as 12% undervalued.
Result: Fair Value of $86.80 (UNDERVALUED)
Still, the GE HealthCare Technologies story can unwind if Patient Care Solutions continues to weigh on group margins, or if tariff costs in China and the U.S. flare up again.
Find out about the key risks to this GE HealthCare Technologies narrative.
Next Steps
Mixed signals on GE HealthCare Technologies so far. If you want to move fast and think for yourself, weigh up the 3 key rewards and 1 important warning sign.
Want more ideas beyond GE HealthCare Technologies?
If you stop with GE HealthCare Technologies, you only see one angle. Broaden your watchlist with fresh ideas that match different risk and return preferences.
- Target potential mispricing by scanning a curated set of 29 high quality undervalued stocks that pair stronger fundamentals with prices the market may not fully reflect.
- Build a steadier portfolio by reviewing 30 resilient stocks with low risk scores that score well on resilience and can help smooth out sharp swings elsewhere.
- Get ahead of the crowd by searching through 18 high quality undiscovered gems where solid financials meet lower visibility and less crowded trades.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com